Biotechnology Focus Podcast

Q&A with Rory Francis PEI BioAlliance | 099

Q&A; with Rory Francis PEI BioAlliance   099| Riding the biotech current to PEI  Welcome to another episode of Biotechnology Focus Radio. I am your host – Michelle Currie. Today, I am joined with a special...

Revolutionary research breaks the frontline against HIV and cancer | 097

  Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the Canadian biotech rundown from coast to coast. This week there has been some revolutionary research in HIV,...

With great growth, comes great responsibility | 096

  Welcome to another episode of Biotechnology focus radio! I am your host – Michelle Currie – here to give you the rundown on what is happening in the life sciences sector from coast to coast. This week brought new...

Even at the forefront of change… what’s next? | 095

  Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on what is happening in biotech across the country from coast to coast. There have been some interesting...

Shining the spotlight on Global Biotech Week Interview with Andrew Casey, BIOTECanada | 094

On the line, I have Andrew Casey who is the president and CEO of BIOTECanada. He is responsible for the day-to-day operations of the association and is the primary spokesperson for Canada’s biotech industry communicating on the industry’s behalf of government,...

Would you pass the salt? | 093

  This week brings around new research from an international study that claims an average sodium intake does not harm your health; NSERC grants 1.65 million for a new biomedical technology program; Prometic Life Sciences elucidates the mechanism of action of their...

Innovation is Everywhere | 092

  Even though we have been having a terrific summer, innovation doesn’t just stop when the sun is beckoning, and the cottage is calling our name. It persists through rain and shine, and never has that been truer. Keep...

Discovering biomarkers and new potential therapies | 091

Welcome to another episode of Biotechnology Focus radio. I am your host – Michelle Currie – here to give you the lowdown on the Canadian biotech scene. This episode I will be discussing how new biomarkers found in maternal...

Canada in the limelight | 090

Welcome to another episode of Biotechnology Focus radio. I am your host – Michelle Currie – here to give you the rundown on the Canadian biotech scene! Coming up we have some inspiring research from the University of Alberta...

Changing the face of disease and pain | 089

    This week we have some encouraging findings on Alzheimer’s as researchers hunt for a cure, there were two research studies released from the University of Toronto: one involving aneurysms, and the other discussing ‘invisible’ pain, as well...

Canada springs to motion, and not just with the weather | 088

  Welcome back to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on the Canadian biotech scene. So, as many of you know, we are coming up...

Shifting thoughts and actions | 087

087 | Shifting thoughts and actions     Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on the Canadian biotech scene. This...

Paving the way of the future | 086

086 | Paving the way of the future      Welcome to another episode of Biotechnology Focus radio! This week Toronto got their socks knocked off by an announcement from Sanofi; a Chinese company expresses interest...

When it sounds more sci-fi than fact | 085

085 | When it sounds more sci-fi than fact  Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on what’s happening on the Canadian biotech...

Canada Talks Pharma | 084

Welcome to another episode of Biotechnology Focus radio – I am your host Michelle Currie. This week I will share with you an interesting article that I came across and then we will move on to the foremost part of the...

Anywhere from infectious diseases to splicing and dicing RNA | 083

Welcome to another episode of Biotechnology Focus radio! I am your host, Michelle Currie, here to give you the rundown on Canada’s biotech scene. This week we have stories about a possible Ebola treatment, how there may be a link...

Discoveries: contending with the superbugs | 082

082 | Discoveries: contending with the superbugs  Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on what’s happening on the Canadian biotech scene. This...

Life sciences is abuzz for Canadians | 081

Welcome to another episode of Biotechnology Focus radio. I am your host – Michelle Currie – here to give you the rundown on the Canadian biotech scene. This week I’ll be discussing how the regenerative medicine community is abuzz,...

Pursuing cures and advancing innovation | 080

080 | Pursuing cures and advancing innovation   Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on what’s been happening on Canada’s biotech scene. It...

079 | Acknowledging some of the industry’s best

079 | Acknowledging some of the industry’s best Welcome to another episode of Biotechnology Focus radio. I am your host, Michelle Currie, here to give you the lowdown on the Canadian biotech scene. Today, I will be discussing such topics...

078 | Investing, combating and treating

Welcome to another episode of Biotechnology Focus radio. This week we are discussing a recent investment, the engineering of a CAR molecule to combat cancer, a new surgical treatment and a study notifying us that viruses are literally falling to...

077 | Mergers, grants and machines

Welcome to another episode of Biotechnology Focus radio. This week we are discussing some of the recent mergers and acquisitions that have been rocking the headlines, some recently awarded grants and how machines are moving fast. I am your...

076 | Regulations, Drug Discovery, and Collaborations

076 | Regulations, Drug Discovery, and Collaborations Welcome to another episode of Biotechnology Focus radio. This week we’ll be discussing regulations when working with drugs, financing drug discoveries, and an East Coast collaboration that will develop new opportunities for marine...

075 | Partnerships, potential cures and pandemics

075 | Partnerships, potential cures and pandemics      Welcome to another episode of Biotechnology Focus radio. This week has brought new partnerships and novel research to light from across Canada.   An international...

074 | An unprecedented act of kindness, a jump in cancer immunotherapy, and trusting your gut

074 | An unprecedented act of kindness, a jump in cancer immunotherapy, and trusting your gut On this episode of Biotechnology Focus radio are some of the top stories this week: How an unprecedented act of kindness will transform lives...

073 | Digitalizing clinical trials, dangerous vaccines and hope for HIV

Happy 2018 from Biotechnology Focus! Ahead on today’s episode are some of the headlines that are shaking things up in the new year.   Sanofi launches digital clinical trials for increased probability of participation  A repurposed...

072 | ImmunoBiochem is haloed with angel investors, BioTalent Canada provides subsidy for more “green jobs”, giving the gift of sight and more

Ahead of Biotechnology Focus radio are some of the highlights of the week. ImmunoBiochem is haloed with angel investors after completing a new round of financing. Biotalent Canada provides subsidy to fund more “green jobs” for young graduates. eSight named...

071 | Alzheimer's might be a whole-body problem, key protein identified, real-time study of astronauts and more

Ahead on Biotechnology Focus radio are some of the stories from universities across the country and their innovative research this week. The University of British Columbia presents research that Alzheimer’s might be a whole-body problem. The University of Guelph identifies...

070 | Outsourcing Podcast with Michael Stopay from Pacer Air Freight

Hi! This is Michelle Currie and on this episode of Biotechnology Focus radio, we will be discussing outsourcing. A topic defined as “the strategic use of outside resources to perform activities traditionally handled by internal staff and resources.” It is...

069 | Drug companies fined, new digital pill, Mississauga - A stem hub for success

The field of biotechnology is constantly evolving. It encompasses everything that harnesses cellular and biomolecular processes to develop technologies and products that will improve our lives and the health of our planet. This is Michelle Currie with the breaking biotechnology...

068 | More takeaways from 2017 Bio Employee Survey

In the previous episode of the Biotechnology Focus podcast, we heard from Dean Fulford, vice-president of Stratford Managers Corp. talked about the impact that a younger cohort of workers on the biotech industry. We’re still on the topic of the...

067 | 2017 Bio Employee Survey – The millennials want to be heard

In this episode of the Biotechnology Podcast, Dean Fulford, vice-president of HR consulting for Stratford Managers Corp. discusses some key points from the recently concluded 2017 Bio Employee Survey conducted by Biotechnology Focus, Stratford Managers and BioTalent Canada. A younger...

066 | 2017 Bio Employee Survey results reveal encouraging workplace trend

The results of this year’s Bio Employee Survey are in. And for this week’s episode of the Biotechnology Focus podcast, we’re providing you with an exclusive sneak peek of what the pollsters found. The follow-on poll to Canada’s first-ever biotech...

065 | 3SBIO purchase Therapure Biopharma, a CAR-T trial patient dies, and Mavenclad makes a breakthrough

China’s 3SBio gains a North American through its $290 million purchase of Canada’s Therapure Biopharma Marck’s cladribine tablet Mavenclad achieves sustained control of relapsing multiple sclerosis. A patient enrolled in a CAR-T trial dies. I’m Nestor Arellano. And these are...

064 | BioTalent Canada chief talks about the life science talent gap

In this episode of the Biotechnology Focus podcast, Rob Henderson, the president and CEO of BioTalent Canada, discusses what can be done to avert a life science industry talent shortage and why it is important to take the pulse of the...

063 | Canadian life science industry HR survey

What are the things that employees in Canada’s life sciences sector value about their workplace? What attributes of their organization keep them engage and productive each day? How can you, as an employer attract and retain great talent? How can...

062 | Pancreatic cancer treatment, three HIV drugs, farewell to Mario Lebrun

  Mario Lebrun, former BIO Quebec managing director passes away, Mylan introduces three generic drugs for HIV, and Shire Pharma’s Onivide has been approved for metastatic adeno carcinoma of the pancreas. In this week’s Biotechnology Focus Podcast, we observe the...

061 | Canada's BioTech industry is on a roll, and could the body be protecting cancer cells?

060 | Intellipharmaceutics’ face lawsuit over tamper resistant opioid, IDT tackles CRISPR off-targets

The ups and down of an Ontario-based pharma company seeking to develop a solution for the world’s deadly opioid epidemic. A custom DNA nucleotide maker locks in on the problem of CRISP Cas9 off-targets I’m Nestor Arellano. And these are...

059 | Creative Destruction, lime disease defence, cell therapy for pets

Creative Destruction Lab probably conjures up images of exploding beakers and test tubes, or worse a company that demolishes buildings. If you’re a researcher or scientist working on potential new treatment or therapy. If you’re a founder or a fledgling...

O58 | Michael May of CCRM talks about how to make the perfect pitch

And, that was Dr. Christopher Gemmiti, a regenerative medicine professional, making a pitch before a panel of judges, for his company RedactBio. This was during the Perfect Pitch competition held at the recent Toronto conference The Business of Regenerative Medicine....

057 | Vatche Bartekian of Vantage Bio Trials speaks about Canada Talks Pharma 2017

From September 11th to the 12th this year, Vantage Bio trials will be holding its 2nd annual Canada Talks Pharma conference. The event is an opportunity for professionals in the biotechnology and pharmaceutical industries to get together, exchange views, and...

056 | Merck’s new cholesterol pill, PlantForm goes to Brazil, and Mississauga shed its Pill Hill image

In this episode of the Biotechnology Podcast, we report of the successful results of Merck’s anacetrapib trials. Dr. Don Stewart, principal of Canadian biotech firm PlantForm discusses why his company is building a laboratory in Brazil. We also take a...

055 | Interview with Gordon McCauley, President and CEO of the Centre For Drug Research and Development

By now, it’s no longer a surprise for anyone that the medical marijuana market in the country is geared for explosive growth. Recently Canada’s national drug development and commercialization centre has partnered with Vancouver’s Aequus Pharmaceuticals Inc., on a research program...

054 |CRISPR warnings, Tragically and medical cannabis, U of G genome researchers and more

CRISPR genome editing could hold the key for treating and curing diseases such as cancer, leukemia, and HIV/AIDS. But However, Dr. J. Keith Joung of Massachusetts General Hospital warns there is growing evidence that CRISPR could alter regions of the...

Winterlight Labs' Liam Kaufman on using AI to detect cognitive conditions

In this episode of the Biotechnology Focus Radio, Liam Kaufman, co-founder of Winterlight Labs discusses with us how AI is powering his company’s speech-based diagnostic platform. This platform natural speech to detect and monitor dementia, aphasia, and various cognitive conditions....

052 | Merus Sintrom, Commense, and McPeak-Sirois with the Quebec Breast Cancer Foundation

In this episode of the Biotechnology Focus Radio, we discuss the approval in Spain of Merus Lab's Sintrom medication.   Microbiome research firm Commense licenses from the University of British Columbia, a biotherapeutic for preventing childhood asthma.   The McPeak-Sirois Groupo...

051 | Science Minister Kirsty Duncan speaks on biotechnology and innovation

  At a recent Mississauga Board of Trade event, we caught up with Canada’s Science Minister, the Hon. Kirsty Duncan. Fresh from her trip to Washington, where she spoke with American scientists and championed the need for greater cross-border collaborative...

050 | Catching up with Brian Bloom of Bloom Burton and Co

049 | Microdermics and its quest for less painful injections

Over 1 billion people around the world suffer from "needle phobia." Each year, there are countless people who avoid critical therapies and vaccinations simply because of their fear of hypodermic needles. Vancouver's Microdermics Inc.is determined to change all that with...